[Experience in using an autovaccine in treating patients with chronic osteomyelitis].
Autovaccine immunization (AI) of 60 patients with chronic osteomyelitis resulted in 93% success (significant in 43%) in formerly failures both with surgical and medical treatment. The method of manufacturing the autovaccine is described, immunization schemes are given.
Sologub
V V
VV
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001419:Bacteria / Q000302:isolation & purification; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000302:isolation & purification; D002908:Chronic Disease; D003131:Combined Modality Therapy; D006801:Humans; D016233:Immunotherapy, Active / Q000009:adverse effects / Q000379:methods*; D010019:Osteomyelitis / Q000382:microbiology / Q000628:therapy*; D013997:Time Factors
D000900:Anti-Bacterial Agents; D001428:Bacterial Vaccines
Opyt primeneniia autovaktsiny v lechenii bol'nykh khronicheskim osteomielitom.